Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Recs

1
Player Avatar chtrplyr (24.80) Submitted: 6/6/2008 3:29:10 PM : Underperform Start Price: $17.35 CLDX Score: +68.76

It will be bought out at $5 when it runs out of money which is has none of now along with huge losses.

Featured Broker Partners


Advertisement